Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology.
Schilling S; Zeitschel U; Hoffmann T; Heiser U; Francke M; Kehlen A; Holzer M; Hutter-Paier B; Prokesch M; Windisch M; Jagla W; Schlenzig D; Lindner C; Rudolph T; Reuter G; Cynis H; Montag D; Demuth HU; Rossner S; Nature Medicine, 2008, vol. 14, issue 10, p 1106, ISSN 1546170x. ISBN 1546170x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef